thiazolyl blue has been researched along with carboplatin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashihara, K; Hino, M; Kobayashi, K; Nakahiro, K; Niitani, H; Takemoto, T; Wasai, S | 1 |
| de Leij, L; de Vries, EG; Hospers, GA; Meijer, C; Mulder, NH; Uges, DR | 1 |
| Efferth, T; Fabry, U; Glatte, P; Osieka, R | 1 |
| Debski, R; Juraszewska, E; Malinowska, I; Mazur, B; Ploszynska, A; Stanczak, E; Stefaniak, J; Styczynski, J; Szczepanski, T; Wysocki, M | 1 |
| Blumenthal, RD; Goldenberg, DM; Leone, E; Modrak, D; Rodriguez, M | 1 |
| Chen, G; Guo, L; Liu, J; Wang, Y; Yin, F; Zheng, X | 1 |
| Asad, Y; Banerji, U; Eccles, SA; Jackman, AL; Judson, I; Raynaud, F; Ruddle, R; Sain, N; Sharp, SY; Valenti, M; Walton, M; Workman, P | 1 |
| Chen, HQ; Feng, G; He, J; Hu, J; Wang, DZ | 1 |
| Cambar, J; De Giorgi, F; Ichas, F; L'Azou, B; Passagne, I; Pédeboscq, S; Pometan, JP | 1 |
| Bienemann, A; Castrique, E; Cox, A; Gill, S; McLeod, C; Pugh, J; Taylor, H; White, E; Wyatt, M | 1 |
| Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y | 1 |
| Cui, H; Goddard, R; Hamacher, A; Kassack, MU; Pörschke, KR | 1 |
12 other study(ies) available for thiazolyl blue and carboplatin
| Article | Year |
|---|---|
[Estimating doses of anti-cancer agents in sensitivity tests in vitro].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Mitomycin; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay | 1992 |
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cell Line; Cisplatin; Coloring Agents; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1990 |
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.
Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.
Topics: Carboplatin; Cell Survival; Child; Cisplatin; Coloring Agents; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tetrazolium Salts; Thiazoles; Time Factors; Treatment Outcome; Tumor Cells, Cultured | 2002 |
An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression.
Topics: Antineoplastic Agents; Carboplatin; Cell Division; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Antagonism; Drug Resistance, Neoplasm; Drug Synergism; Female; Genetic Therapy; Humans; In Vitro Techniques; Mutation; Ovarian Neoplasms; Paclitaxel; Radioimmunotherapy; Tetrazolium Salts; Thiazoles; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Yttrium Radioisotopes | 2004 |
Characterization and antitumor activity of triethylene tetramine, a novel telomerase inhibitor.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Blotting, Western; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Doxorubicin; Female; HeLa Cells; Humans; Indicators and Reagents; Mice; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma 180; Telomerase; Tetrazolium Salts; Thiazoles; Trientine | 2008 |
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Blotting, Western; Carboplatin; Cell Line, Tumor; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Ovarian Neoplasms; Rhodamines; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2008 |
A new method to induce multi-drug resistance to carboplatin in a mouse model of human tongue squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Coloring Agents; Disease Models, Animal; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione Transferase; Humans; Immunohistochemistry; Injections, Intradermal; Mice; Mice, Inbred BALB C; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Tetrazolium Salts; Thiazoles; Tongue Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2008 |
Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Boronic Acids; Bortezomib; Brain Neoplasms; Carboplatin; Carmustine; Cell Line, Tumor; Dacarbazine; Dose-Response Relationship, Drug; ErbB Receptors; Flow Cytometry; Gefitinib; Glial Fibrillary Acidic Protein; Glioblastoma; Immunohistochemistry; Indicators and Reagents; Mice; Proteasome Inhibitors; Pyrazines; Quinazolines; Rats; Temozolomide; Tetrazolium Salts; Thiazoles | 2008 |
An evaluation of the safety and feasibility of convection-enhanced delivery of carboplatin into the white matter as a potential treatment for high-grade glioma.
Topics: Animals; Antineoplastic Agents; Brain; Carboplatin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Feasibility Studies; Glial Fibrillary Acidic Protein; Glioma; Half-Life; Humans; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Rats; Rats, Wistar; Spectrophotometry, Atomic; Swine; Tetrazolium Salts; Thiazoles; Time Factors; Tissue Distribution | 2012 |
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Bispidine analogues of cisplatin, carboplatin, and oxaliplatin. synthesis, structures, and cytotoxicity.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Coloring Agents; Humans; Models, Molecular; Molecular Conformation; Organoplatinum Compounds; Oxaliplatin; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles | 2014 |